TNDM Insider Trading
TANDEM DIABETES CARE INC | Surgical & Medical Instruments & Apparatus
Comprehensive Trading Performance Summary
The investment history of corporate insiders at TANDEM DIABETES CARE INC provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2020-08-05 03:13 | 2020-07-31 | Morrison Susan | Officer - EVP & Chief Admin. Officer | OPT+S | $108.58 | 50,000 | $5,429,080 | 6,256 | 0.0% |
| 2020-08-05 03:09 | 2020-07-31 | Vosseller Leigh | Officer - EVP & CHIEF FINANCIAL OFFICER | OPT+S | $110.03 | 10,000 | $1,100,319 | 4,520 | 0.0% |
| 2020-08-05 03:07 | 2020-08-03 | HANSEN BRIAN B | Officer - EVP & CHIEF COMMERCIAL OFFICER | OPT+S | $105.86 | 23,954 | $2,535,766 | 4,665 | 0.0% |
| 2020-08-05 03:06 | 2020-08-03 | Sheridan John F | Officer - PRESIDENT & CEO | OPT+S | $102.21 | 33,200 | $3,393,233 | 3,756 | 0.0% |
| 2020-08-05 03:11 | 2020-07-31 | TWOMEY CHRISTOPHER J | Director | SELL | $110.04 | 7,500 | $825,320 | 17,500 | -30.0% |
| 2020-07-07 23:39 | 2020-07-06 | Vosseller Leigh | Officer - EVP & CHIEF FINANCIAL OFFICER | OPT+S | $105.04 | 10,000 | $1,050,387 | 4,520 | 0.0% |
| 2020-07-07 23:40 | 2020-07-06 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $101.66 | 2,000 | $203,310 | 4,566 | 0.0% |
| 2020-07-07 23:40 | 2020-07-02 | TWOMEY CHRISTOPHER J | Director | SELL | $100.28 | 7,500 | $752,074 | 20,000 | -27.3% |
| 2020-07-03 01:19 | 2020-06-30 | Vosseller Leigh | Officer - EVP & CHIEF FINANCIAL OFFICER | OPT+S | $97.74 | 20,000 | $1,954,750 | 4,520 | 0.0% |
| 2020-07-03 01:20 | 2020-06-30 | BLICKENSTAFF KIM D | Director | SELL | $95.57 | 50,000 | $4,778,400 | 584,593 | -7.9% |
| 2020-06-04 23:33 | 2020-06-03 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $81.81 | 2,000 | $163,623 | 4,566 | 0.0% |
| 2020-05-08 23:25 | 2020-05-07 | Allen Dick | Director | SELL | $89.00 | 3,500 | $311,500 | 1,000 | -77.8% |
| 2020-05-08 23:23 | 2020-05-07 | Vosseller Leigh | Officer - EVP & CHIEF FINANCIAL OFFICER | OPT+S | $90.07 | 10,000 | $900,746 | 3,265 | 0.0% |
| 2020-05-08 23:24 | 2020-05-07 | TWOMEY CHRISTOPHER J | Director | SELL | $90.03 | 7,500 | $675,215 | 22,500 | -25.0% |
| 2020-05-05 01:13 | 2020-05-04 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $78.33 | 2,000 | $156,650 | 3,311 | 0.0% |
| 2020-05-05 01:12 | 2020-04-30 | TWOMEY CHRISTOPHER J | Director | SELL | $80.00 | 4,308 | $344,640 | 25,000 | -14.7% |
| 2020-04-08 23:18 | 2020-04-06 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $67.59 | 2,000 | $135,180 | 3,311 | 0.0% |
| 2020-03-05 00:49 | 2020-03-03 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $77.16 | 2,000 | $154,329 | 3,311 | 0.0% |
| 2020-02-29 02:03 | 2020-02-26 | Allen Dick | Director | OPT+S | $78.82 | 2,979 | $234,805 | 37,179 | 0.0% |
| 2020-02-25 00:35 | 2020-02-21 | Sheridan John F | Officer - PRESIDENT & CEO | OPT+S | $87.86 | 30,000 | $2,635,887 | 2,501 | 0.0% |
| 2020-02-15 00:16 | 2020-02-13 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $82.67 | 16,000 | $1,322,693 | 3,311 | 0.0% |
| 2020-02-13 00:16 | 2020-02-10 | Vosseller Leigh | Officer - EVP & CHIEF FINANCIAL OFFICER | OPT+S | $80.04 | 10,000 | $800,353 | 3,265 | 0.0% |
| 2020-02-05 00:10 | 2020-02-03 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $75.46 | 2,000 | $150,912 | 3,311 | 0.0% |
| 2020-02-01 02:28 | 2020-01-29 | Allen Dick | Director | OPT+S | $75.93 | 10,371 | $787,450 | 0 | 0.0% |
| 2020-02-01 02:27 | 2020-01-29 | HANSEN BRIAN B | Officer - EVP & CHIEF COMMERCIAL OFFICER | OPT+S | $75.80 | 50,000 | $3,790,100 | 2,991 | 0.0% |
| 2020-02-01 01:23 | 2020-01-29 | Vosseller Leigh | Officer - EVP & CHIEF FINANCIAL OFFICER | OPT+S | $75.93 | 10,000 | $759,253 | 3,265 | 0.0% |
| 2020-02-01 01:21 | 2020-01-29 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $74.62 | 12,000 | $895,470 | 3,311 | 0.0% |
| 2020-02-01 01:22 | 2020-01-29 | BLICKENSTAFF KIM D | Director, Officer - Executive Chairman | SELL | $75.92 | 50,000 | $3,796,125 | 641,750 | -7.2% |
| 2020-01-18 02:57 | 2020-01-16 | HANSEN BRIAN B | Officer - EVP & CHIEF COMMERCIAL OFFICER | OPT+S | $69.76 | 10,000 | $697,620 | 2,991 | 0.0% |
| 2020-01-18 02:59 | 2020-01-16 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $67.83 | 8,000 | $542,640 | 3,311 | 0.0% |
| 2019-12-19 00:26 | 2019-12-16 | BLICKENSTAFF KIM D | Director, Officer - Executive Chairman | SELL | $59.85 | 200,000 | $11,970,500 | 691,750 | -22.4% |
| 2019-11-27 03:38 | 2019-11-25 | Vosseller Leigh | Officer - EVP & CHIEF FINANCIAL OFFICER | OPT+S | $70.35 | 10,000 | $703,500 | 3,265 | 0.0% |
| 2019-11-27 03:36 | 2019-11-25 | Sheridan John F | Officer - PRESIDENT & CEO | OPT+S | $70.00 | 462 | $32,340 | 2,501 | 0.0% |
| 2019-11-19 03:12 | 2019-11-18 | Vosseller Leigh | Officer - EVP & CHIEF FINANCIAL OFFICER | OPT+S | $65.41 | 10,000 | $654,128 | 3,265 | 0.0% |
| 2019-11-07 01:13 | 2019-11-04 | HANSEN BRIAN B | Officer - EVP & CHIEF COMMERCIAL OFFICER | OPT+S | $62.01 | 15,000 | $930,131 | 2,991 | 0.0% |
| 2019-09-09 23:20 | 2019-09-06 | Sheridan John F | Officer - PRESIDENT & CEO | OPT+S | $70.03 | 9,538 | $667,946 | 2,501 | 0.0% |
| 2019-09-04 02:27 | 2019-09-03 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $72.00 | 2,000 | $144,000 | 3,311 | 0.0% |
| 2019-08-30 23:19 | 2019-08-28 | BLICKENSTAFF KIM D | Director, Officer - Executive Chairman | SELL | $70.96 | 100,000 | $7,096,200 | 891,750 | -10.1% |
| 2019-08-30 02:56 | 2019-08-27 | ROEDER DOUGLAS A | Director | SELL | $70.32 | 308,297 | $21,680,370 | 9,670 | -97.0% |
| 2019-08-28 23:09 | 2019-08-27 | HANSEN BRIAN B | Officer - EVP & CHIEF COMMERCIAL OFFICER | OPT+S | $70.00 | 6,969 | $487,830 | 2,991 | 0.0% |
| 2019-08-14 23:06 | 2019-08-13 | CAHILL EDWARD L | Director | OPT+S | $63.03 | 1,417 | $89,314 | 3,982 | 0.0% |
| 2019-08-13 23:53 | 2019-08-12 | HANSEN BRIAN B | Officer - EVP & CHIEF COMMERCIAL OFFICER | OPT+S | $62.97 | 15,000 | $944,550 | 2,991 | 0.0% |
| 2019-08-06 23:14 | 2019-08-02 | HANSEN BRIAN B | Officer - EVP & CHIEF COMMERCIAL OFFICER | OPT+S | $70.01 | 5,000 | $350,050 | 2,991 | 0.0% |
| 2019-08-06 23:13 | 2019-08-05 | GREENE HOWARD E JR | Director | SELL | $61.50 | 10,000 | $615,038 | 30,000 | -25.0% |
| 2019-08-06 23:17 | 2019-08-05 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $62.56 | 2,000 | $125,120 | 3,311 | 0.0% |
| 2019-08-07 01:54 | 2019-08-02 | ROEDER DOUGLAS A | Director | SELL | $70.01 | 9,471 | $663,076 | 12,651 | -42.8% |
| 2019-07-16 00:12 | 2019-07-11 | ROEDER DOUGLAS A | Director | SELL | $70.08 | 13,347 | $935,375 | 12,743 | -51.2% |
| 2019-07-13 00:43 | 2019-07-11 | HANSEN BRIAN B | Officer - EVP & CHIEF COMMERCIAL OFFICER | OPT+S | $70.04 | 13,031 | $912,691 | 2,991 | 0.0% |
| 2019-07-08 23:04 | 2019-07-03 | BERGER DAVID B | Officer - EVP, Chief Legal & Compliance | OPT+S | $63.60 | 2,000 | $127,200 | 3,311 | 0.0% |
| 2019-06-18 00:02 | 2019-06-13 | ROEDER DOUGLAS A | Director | SELL | $70.07 | 35,688 | $2,500,647 | 12,872 | -73.5% |
How to Interpret $TNDM Trades
Not every insider transaction in TANDEM DIABETES CARE INC is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $TNDM shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for TNDM
Insider activity data for TANDEM DIABETES CARE INC is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $TNDM, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.